Defense Health Program Department of Defense Ovarian Cancer Research Program Anticipated Funding Opportunities for Fiscal Year 2021 (FY21)

How to Apply: 

FY21 OCRP Program Announcements and General Application Instructions for the following award mechanism are posted on the website.


Omics Consortium Award – Preapplication due June 24, 2021


Must be an independent investigator at or above the level of Assistant Professor (or equivalent).

  • Supports a multi-institutional research effort conducted by leading cancer researchers and advocates that focuses on the compilation of new and/or use of existing large datasets to study the origin of ovarian cancer, with an emphasis on early detection and screening.

Two options are available:

Omics Development Award Option:

  • Funds support assembling consortium members and laying the groundwork for the research project, including proof of concept.
  • Ovarian cancer advocate(s) are required on the research team.
  • Funded applicants will be eligible to compete for the consortium award, which will support the execution of the full research project and is anticipated to be offered in FY23, pending availability of funds.

Omics Consortium Award Option:

  • The research effort will provide immediate benefits for ovarian cancer patients in initial diagnosis and therapy and the end result will lead to improvements in early detection and screening detection of ovarian cancer. 
  • Consortium should maximize the use of resources and minimize unnecessary duplication among consortium members by sharing resources among all consortium members.
  • Ovarian cancer advocate(s) are required on the research team.
  • Submission of a Letter of Intent is required prior to full application submission.

Omics Development Award Option:

  • Maximum funding of $400,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.

Omics Consortium Award Option:

  • Maximum funding of $2.5 million for direct costs (plus indirect costs) from FY21 and future appropriations.
  • Maximum period of performance is years


A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at prior to the pre-application deadline.  All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the website.  The application package containing the required forms for each award mechanism will also be found on  A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the website by performing a basic search using CFDA Number 12.420. 


For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at  For more information about the OCRP or other CDMRP-administered programs, please visit the CDMRP website (


Point of Contact:

CDMRP Help Desk


External Deadline: 
Thursday, June 24, 2021
Funding Source: 
Funding Level: